Prof. MUDr. Miroslav Merta, CSc., Ph.D.
Lékařská fakulta v Hradci Králové
Prof. MUDr. Miroslav Merta, CSc., Ph.D. je autorem těchto článků v časopise Postgraduální nefrologie:
Cornec‑Le Gall E, Audrézet MP, Chen JM, Hourmant M, Morin MP, Perrichot R, Charasse C, Whebe B, Renaudineau E, Jousset P, Guillodo MP, Grall‑Jezequel A, Saliou P, Férec C, Le Meur Y. Type of PKD1 mutation influences renal outcome in ADPKD. J Am Soc Nephrol 2013;24:1006–1013.
Saeki T, Kawano M, Mizushima I, Yamamoto M, Wada Y, Nakashima H, Homma N, Tsubata Y, Takahashi H, Ito T, Yamazaki H, Saito T, Narita I. The clinical course of patients with IgG4‑related kidney disease. Kidney Int 2013, May 22. doi: 10.1038/ki.2013.191
Grooteman MP, van den Dorpel MA, Bots ML, Penne EL, van der Weerd NC, Mazairac AH, den Hoedt CH, van der Tweel I, Lévesque R, Nubé MJ, Ter Wee PM, Blankestijn PJ; for the CONTRAST Investigators. Effect of online hemodiafiltration on all‑cause mortality and cardiovascular outcomes. J Am Soc Nephrol 2012;23:1087–1096.
Van Biesen W, Verbeke F, Vanholder R. An infallible recipe? A story of cinnamon, souffle and metaanalysis. Nephrol Dial Transplant 2008;23: 2729–2732.
Consugar MB, Wong WC, Lundquist PA, Rossetti S, Kubly VJ, Walker DL, Rangel LJ, Aspinwall R, Niaudet WP, Ozen S, David A, Velinov M, Bergstralh EJ, Bae KT, Chapman AB, Guay-Woodford LM, Grantham JJ, Torres VE, Sampson JR, Dawson BD, Harris PC; CRISP Consortium. Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome. Kidney Int 2008;74:1468–1479.
Tong A, Chapman S, Sainsbury P, Craig JC. An analysis of media coverage on the prevention and early detection of CKD in Australia. Am J Kidney Dis 2008; 52:159–170.
Hsu CY, Ordońez JD, Chertow GM, et al. The risk of acute renal failure in patients with chronic kidney disease. Kidney Int 2008;74:101–107.
Ruggenenti P, Perticucci E, Cravedi P, et al. Role of remission clinics in the longitudinal treatment of CKD. J Am Soc Nephrol 2008;19:1213–1224.
Baboolal K, McEwan P, Sondhi S, Spiewanowski P, Wechowski J, Wilson K. The cost of renal dialysis in a UK setting – a multicentre study. Nephrol Dial Transplant 2008;23:1982–1989.
Moist LM, Bragg.Gresham JL, Pisoni RL, Saran R, Akiba T, Jacobson SH, Fukuhara S, Mapes DL, Rayner HC, Saito A, Port FK. Travel time to dialysis as a predictor of health.related quality of life, adherence, and mortality: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2008; 51:641.650.
Dooley AC, Weiss NS, Kestenbaum B. Increased risk of hip fracture among men with CKD. Am J Kidney Dis 2008 Jan;51(1):38–44.
Fan SL, Pile T, Punzalan S, Raftery MJ, Yaqoob MM. Randomized controlled study of biocompatible peritoneal dialysis solutions: effect on residual renal function. Kidney Int 2008;73:200–206.
Mehrotra R, Kermah D, Fried L, Kalantar-Zadeh K, Khawar O, Norris K and Nissenson A. Chronic peritoneal dialysis in the United States: declining utilisation despote improving outcomes. J Am Soc Nephrol 2007;18:2781–2788.
Bjorneklett R, Vikse BE, Svarstad E, Aasarod K, Bostad L, Langmark F, Iversen BM. Long-term risk of cancer in membranous nephropathy patients. Am J Kidney Dis 2007;50:396–403.
Segall L, Covic A, Goldsmith DJ. Direct renin inhibitors: the dawn of a new era, or just a variation on a theme? Nephrol Dial Transplant 2007;22:2435–2439.
Hutchison CA, Dasgupta I. National survey of heparin-induced thrombocytopenia in the haemodialysis population of the UK population. Nephrol Dial Transplant 2007;22:1680–1684.
Jones-Burton C, Vessal G, Brown J, Dowling TC, Fink JC. Urinary cotinine as an objective measure of cigarette smoking in chronic kidney disease. Nephrol Dial Transplant 2007;22:1950–1954.
Hagiwara S, Saima S, Negishi K, Takeda R, Miyauchi N, Akiyama Y, Horikoshi S, Tomino Y. High incidence of renal failure in patients with aortic aneurysms. Nephrol Dial Transplant 2007;22:1361–1368.
Praga M, Barrio V, Juarez GF, Luno J; Grupo Espanol de Estudio de la Nefropatia Membranosa. Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trial. Kidney Int 2007;71:924–30.
Mancini E, Mambelli E, Irpinia M, et al. Prevention of dialysis hypotension episodes using fuzzy logic control system. Nephrol Dial Transplant 2007;22:1420–1427.
Block GA, Raggi P, Bellasi A, Kooienga L, Spiegel DM. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 2007;71:438–441.
Tostivint I, du Montcel ST, Jaudon MC, Mallet A, Le Hoang P, Bodaghi B, Deray G, Bagnis CI. Renal outcome after ciclosporin‑induced nephrotoxicity. Nephrol Dial Transplant 2007;22:880–885.
Grudzinski L, Quinan P, Kwok S, Pierratos A. Sodium citrate 4% locking solution for central venous dialysis catheters — an effective, more cost‑efficient alternative to heparin. Nephrol Dial Transplant 2007;22:471‑6.
Cunningham J. Pathogenesis and prevention of bone loss in patients who have kidney disease and receive long‑term immunosuppression. J Am Soc Nephrol 2007;18:223–234.
Mondry A, Loh M, Laurence KB, Low N. DNA polymorphisms and renal disease: a critical appraisal of studies presented at the annual ERA/EDTA and ASN conferences in 2004 and 2005. Nephrol Dial Transplant 2006;21:2775–2779.
Cho KC, Himmelfarb J, Paganini E, Ikizler TA, Soroko SH, Mehta RL, Chertow GM. Survival by dialysis modality in critically ill patients with acute kidney injury. J Am Soc Nephrol 2006;17:3132–3138.
Goel N, Miller GA, Jotwani MC, Licht J, Schur I, Arnold WP.: Minimally Invasive Limited Ligation Endoluminal-assisted Revision (MILLER) for treatment of dialysis access-associated steal syndrome. Kidney Int 2006;70:765–770.
Tumkur SM, Vu AT, Li LP, Pierchala L, Prasad PV.: Evaluation of intra-renal oxygenation during water diuresis: a time-resolved study using BOLD MRI. Kidney Int 2006;70:139–143.
Macgregor MS, Agar JW, Blagg CR. Home haemodialysis – international trends and variation. Nephrol Dial Transplant 2006;21:1934–1945.
Daudon M, Traxer O, Conort P, Lacour B, Jungers P. Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol 2006;17:2026–2033.
Neutel JM.: The role of combination therapy in the management of hypertension. Nephrol Dial Transplant 2006;21:1469-1473.
Ni J, Verbavatz J-M, Rippe A, Boisdé I, Moulin P, Rippe B, Verkman AS, Devuyst O.: Aquaporin-1 plays an essential role in water permeability and ultrafiltration during peritoneal dialysis. Kidney Int 2006;69:1518–1525.
Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, Kimata N, Gillespie BW, Combe C, Bommer J, Akiba T, Mapes DL, Young EW, Port FK. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 2006;69:1222–1228.
Amann K, Haas CS. What you should know about the work-up of a renal biopsy. Nephrol Dial Transplant. 2006;21:1157–1161.
Hoorn EJ, Lindemans J, Zietse R. Development of severe hyponatraemia in hospitalized patients: treatment-related risk factors and inadequate management. Nephrol Dial Transplant 2006;21:70–76.
Muranyi W, Bahr U, Zeier M, van der Woude FJ. Hantavirus infection. J Am Soc Nephrol 2005;16:3669–3679. Epub 2005, Nov 2.
Berger SP, Roos A, Daha MR. Complement and the kidney: What the nephrologist needs to know in 2006? Nephrol Dial Transplant 2005;20:2613–2619.
Vicente E Torres. Vasopressin antagonists in polycystic kidney disease. Kidney Int 2005;68:2405–2418.
Hodanova K, Majewski J, Kublova M, Vyletal P, Kalbacova M, Stiburkova B, Hulkova H, Chagnon YC, Lanouette CM, Marinaki A, Fryns JP, Venkat-Raman G, Kmoch S. Mapping of a new candidate locus for uromodulinassociated kidney disease (UAKD) to chromosome 1q41. Kidney Int 2005;68:1472-1482.
Stokes MB, Foster K, Markowitz GS, Ebrahimi F, Hines W, Kaufman D, Moore B, Wolde D, D´Agati VD.: Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis. Nephrol Dial Transplant 2005;20:1400-1406.
Goovaerts T, Jadoul M, Goffin E. : Influence of a Pre-Dialysis Education Programme (PDEP) on the mode of renal replacement therapy. Nephrol Dial Transplant 2005;20:1842-1847.
Eisenberger U, Fakhouri F, Vanhille P, Beaufils H, Mahr A, Guillevin L, Lesavre P, Noel LH.: ANCA-negative pauci-immune renal vasculitis: histology and outcome. Nephrol Dial Transplant 2005 Jul;20(7):1392-9.
Atkins MB. Management of advanced renal cancer. Kidney Int 2005;67:2069-2082.
Javaid B, Quigg RJ. Treatment of glomerulonephritis: will we ever have options other than steroids and cytotoxics? Kidney Int 2005;67 :1692-1703.
Noris M, Remuzzi G. Hemolytic uremic syndrome. J Am Soc Nephrol 2005;16: 1035–1050.
Wauters JP, Lameire N, Davison A, Ritz E. Why patients with progressing kidney disease are referred late to the nephrologist: on causes and proposals for improvement. Nephrol Dial Transplant 2005;20:490–496.
Tao Y, Kim J, Schrier RW, Edelstein CL. Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease. J Am Soc Nephrol. 2005 Jan;16(1):46–51.
Humphreys BD, Soiffer RJ, Magee CC. Renal failure associated with cancer and its treatment: an update. J Am Soc Nephrol 2005;16:151–161.
Clarkson MR, Giblin L, O´Connell FP, OíKelly P, Walshe JJ, Conlon P, OíMeara Y, Dormon A, Campbell E, Donohoe J. Acute interstitial nephritis: clinical features and response to corticosteroid therapy. Nephrol Dial Transplant 2004;19:2778-2783.
Meyrier A. Nephrotic focal segmental glomerulosclerosis in 2004: an update. Nephrol Dial Transplant. 2004;19:2437-2444.
Textor SC. Ischemic nephropathy: Where are we now? J Am Soc Nephrol 2004;15:1974-1982.
Bagnis CI, Deray G, Baumelou A, Le Quintrec M, Vanherweghem JL. Herbs and the kidney. Am J Kidney Dis 2004;44:1-11.
Weyde W, Badowski R, Krajewska M, Penar J, Moron K, Klinger M. Femoral and iliac vein stenoses after prolonged femoral vein catheter insertion. Nephrol Dial Transplant 2004;19:1618-1621.
Blankestijn PJ. Sympathetic hyperactivity in chronic kidney disease. Nephrol Dial Transplant 2004;19:1354-1357.
Shiiki H, Saito T, Nishitani Y, et al. Research Group on Progressive Renal Diseases in Japan: Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney Int 2004;65:1400-1407.
Rossert J, Casadevall N, Eckardt KU. Anti-erythropoietin antibodies and pure red cell aplasia. J Am Soc Nephrol 2004;15:398-406.
Siamopoulos K.C.: Fabry disease: Kidney involvement and enzyme replacement therapy. Kidney Int 2003; 65:744-753.
Pozzi C, Andrulli S, Del Vecchio L, Melis P, Fogazzi GB, Altieri P, Ponticelli C, Locatelli F. Corticosteroid effectiveness in IgA nephropathy: Long-term results of a randomized, controlled trial. J Am Soc Nephrol 2004;15:157-163.